Serial #99414284
LIVE

Serial Number

99414284

Owner

Zylidac Bio LLC

Attorney

Anthony J. DiMarino

Filing Date

Sep 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #99414284 Trademark

Serial Number: 99414284

Serial #99414284 is a trademark filed by Zylidac Bio LLC on September 26, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Zylidac Bio LLC (5 trademarks)

73 Route 31 N
Pennington, NJ 08534

Entity Type: 03

Trademark Details

Filing Date

September 26, 2025

Registration Date

Not Registered

Published for Opposition

April 14, 2026

Goods & Services

Medical services; Medical clinics; Health care services, namely, wellness programs; Providing a website featuring information about health, wellness and nutrition; Providing information in the fields of health and wellness; Managed health care services; Consulting services in the field of healthcare

Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals; Reagents for scientific or medical research use; Reagents for research purposes; Reagents for scientific purposes; Reagents for scientific use; Chemical diagnostic reagents for scientific use

Research and development in the field of pharmaceuticals; Development of products for others in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Development of pharmaceuticals for cell and gene therapies; Research and development of new products; Technical consulting in the field of pharmaceutical studies; Research and development services of new pharmaceutical products; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Biomedical research services

Biomanufacturing for others of pharmaceuticals using biological organisms in the manufacturing process; Custom manufacture of cancer vaccines; Custom manufacturing of pharmaceuticals

Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Health food supplements; Nutraceuticals for use as a dietary supplement; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Chemical reagents for medical use; Chemical reagents for medical or veterinary use; Diagnostic chemical reagents for medical purposes; Diagnostic chemical reagents for medical use; Reagents for medical use; Clinical medical reagents; Dietary and nutritional supplements; Dietary food supplements; Vitamin and mineral supplements; Herbal supplements; Human vaccine preparations; Vaccine preparations

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 9, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 17, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 17, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 17, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 17, 2026 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 17, 2026 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 10, 2026 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 18, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 18, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 18, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 18, 2026 CNEA
ASSIGNED TO EXAMINER
Feb 17, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 13, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 13, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 26, 2025 MAFR
NEW APPLICATION ENTERED
Sep 26, 2025 NWAP